MedPath

Triamcinolone and Verapamil injection on Keloid scars

Phase 3
Recruiting
Conditions
Surgical keloid lesion.
Hypertrophic scar
L91.0
Registration Number
IRCT20210524051384N6
Lead Sponsor
Rasht University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
16
Inclusion Criteria

The Keloid scar should be at least 0.5 cm long and at most 10 cm
At least 3 months will be passed since their surgery
Patients are in the age range of 18 to 50 years
consent Informed

Exclusion Criteria

Keloid scars with a duration of more than 12 months
Patients with infection or any other disease in the vicinity of the wound
Pregnant patients or those who plan to become pregnant in the near future
Breastfeeding women
Diabetic patients
Patients with high blood pressure or heart problems
People with chronic kidney disease or those who have had any abnormal changes in the CBC or liver tests
Patients taking steroids or verapamil for other conditions
Keloid scars of the head, face and neck

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath